Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Agenus Inca leader in immunooncology innovation and Noetik a leader in AIdriven spatial and multimodal biology today announced a research collaboration to develop predictive biomarkers of response to Agenus lead clinical stage immunooncology IO combi...
Eli Lilly and Company and Verve Therapeutics Inc a Bostonbased clinicalstage company developing genetic medicines for cardiovascular disease today announced a definitive agreement for Lilly to acquire Verve
Royal Philips a global leader in health technology today released the Asia Pacific APAC findings from its th annual Future Health Index FHI report the largest global healthcare survey of its kind
Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine CC delivered via dissolvable microarray technology is now enrolling participants
BIO International Convention In a bold move that may redefine the global future of genomics drug discovery and precision health BioAro Inc a Canadian biotechnology and precision medicine company
HELP Therapeutics a global leader in regenerative medicine and China Resources Sanjiu Pharmaceutical Company one of Chinas largest pharmaceutical companies have announced a strategic partnership to codevelop and commercialize the investigational cell...
Pierre Fabre Laboratories are pleased to announce the acquisition from Antares Therapeutics Inc Antares a spinout of Scorpion Therapeutics Inc of the worldwide rights for PFL and PFL
In just two days the second edition of the London Biotechnology Show LBS returns to ExCeL London on June bringing together one of the most influential gatherings in the global biotechnology calendar
HekaBio KK today announced the signing of a strategic partnership agreement with Alfresa Holdings Corporation Headquarters Chiyodaku Tokyo Representative Director President Ryuji Arakawa hereinafter Alfresa Holdings
Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncology cardiovascular and metabolic autoimmune
